The 12-Membered TNFR1 Peptide, as Well as the 16-Membered and 6-Membered TNF Peptides, Regulate TNFR1-Dependent Cytotoxic Activity of TNF

Daria M. Yurkina,Elena A. Romanova,Anna V. Tvorogova,Zlata K. Naydenysheva,Alexey V. Feoktistov,Denis V. Yashin,Lidia P. Sashchenko
DOI: https://doi.org/10.3390/ijms25073900
IF: 5.6
2024-04-01
International Journal of Molecular Sciences
Abstract:Understanding the exact mechanisms of the activation of proinflammatory immune response receptors is very important for the targeted regulation of their functioning. In this work, we were able to identify the sites of the molecules in the proinflammatory cytokine TNF (tumor necrosis factor) and its TNFR1 (tumor necrosis factor receptor 1), which are necessary for the two-stage cytotoxic signal transduction required for tumor cell killing. A 12-membered TNFR1 peptide was identified and synthesized, interacting with the ligands of this receptor protein's TNF and Tag7 and blocking their binding to the receptor. Two TNF cytokine peptides interacting with different sites of TNFR1 receptors were identified and synthesized. It has been demonstrated that the long 16-membered TNF peptide interferes with the binding of TNFR1 ligands to this receptor, and the short 6-membered peptide interacts with the receptor site necessary for the transmission of a cytotoxic signal into the cell after the ligands' interaction with the binding site. This study may help in the development of therapeutic approaches to regulate the activity of the cytokine TNF.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to identify and synthesize peptides that can regulate the interaction between tumor necrosis factor (TNF) and its receptor TNFR1, in order to regulate the TNF - mediated cytotoxic activity. Specifically, the research aims to: 1. **Identify TNFR1 peptide fragments that interact with TNFR1 ligands**: Look for TNFR1 peptide fragments that can bind to ligands such as TNF and Tag7. These fragments may inhibit cytotoxicity by blocking the binding of ligands to the receptor. 2. **Identify TNF peptide fragments that inhibit the cytotoxicity of TNFR1 ligands**: Look for TNF peptide fragments that can inhibit the cytotoxicity of TNFR1 ligands (such as TNF and Tag7 - Hsp70 complex). 3. **Identify TNF peptide fragments that mimic the cytotoxicity of TNFR1 ligands**: Look for TNF peptide fragments that can mimic the cytotoxicity - effect of TNFR1 ligands. These fragments may activate cytotoxic signaling pathways by binding to specific sites of the receptor. Through these studies, the authors hope to provide new ideas for the development of treatment strategies targeting the TNF signaling pathway, especially by using small peptides to specifically regulate the activity of TNF, so as to achieve the treatment of inflammatory diseases or tumors without causing extensive side effects.